Measuring the quality of life in men with prostate cancer

Men diagnosed with prostate cancer (PCa) choose treatments based on known side effects that impact health-related quality of life (HRQL). This study evaluated the psychometric properties of the UCLA Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12v2).

Saved in:
Bibliographic Details
Published inUrologic nursing Vol. 34; no. 4; pp. 177 - 184
Main Authors Hooper, Gwen, Gerber, Eric
Format Journal Article
LanguageEnglish
Published United States Jannetti Publications, Inc 01.07.2014
Anthony J. Jannetti, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Men diagnosed with prostate cancer (PCa) choose treatments based on known side effects that impact health-related quality of life (HRQL). This study evaluated the psychometric properties of the UCLA Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12v2).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1053-816X
2168-4626
DOI:10.7257/1053-816x.2014.34.4.177